Terumo Corp (TRUMF)

14.85
+0.00 (0.00%)
OP · Last Trade: Jan 12th, 9:53 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close14.85
Open-
Bid-
Ask-
Day's RangeN/A - N/A
52 Week Range13.17 - 20.58
Volume2
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume8,890

Chart

News & Press Releases

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analystbenzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via Benzinga · January 23, 2024